Association of Pathway Mutations With Survival in Taiwanese Breast Cancers

Keyphrases

• Taiwanese 100%
• Poor Prognosis 100%
• Breast Cancer Patients 100%
• Breast Cancer 100%
• Pathway mutation 100%
• Point mutation 50%
• APC mutation 50%
• Functional Point 50%
• High-resolution 25%
• Genome Database 25%
• Breast Tumor 25%
• Next-generation Sequencing 25%
• Tumor mutation Burden 25%
• Clinical High Risk 25%
• ErbB2 25%
• Missense mutation 25%
• Patients with Breast Cancer 25%
• Gene mutation 25%
• Genetic Screening 25%
• Mutation Hotspots 25%
• Invasive Cancer 25%
• Triple-negative Breast Cancer 25%
• Targeted Sequencing 25%
• Mutation Detection 25%
• Single nucleotide Variation 25%
• Sequencing Depth 25%
• Non-synonymous SNP 25%
• Human Breast Cancer 25%
• Runt-related Transcription Factor 1 (RUNX1) 25%
• CDH1 25%
• MAP2K4 25%
• Indel mutation 25%
• FBXW7 25%
• RainDance 25%
• Notch1 25%
• Cancer Hotspot Panel 25%
• Illumina Sequencing 25%
• Possible Treatments 25%
• Cancer Genome 25%
• Asian Breast Cancer 25%
• Fibroblast Growth Factor Receptor 3 (FGFR3) 25%
• 1000 Genomes 25%
• PIK3CA 25%
• TP53 mutation 25%

Biochemistry, Genetics and Molecular Biology

• Point Mutation 100%
• Single Nucleotide Polymorphism 50%
• Single-Nucleotide Polymorphism 50%
• Gene Mutation 50%
• Missense Mutation 50%
• Next Generation Sequencing 50%
• Indel 50%
• Genetic Screening 50%
• Illumina Dye Sequencing 50%
• RUNX1 50%
• MAP2K4 50%
• FBXW7 50%
• Fibroblast Growth Factor Receptor 3 50%